APEX BIOVENTURES ACQUISITION CORP
APEX BIOVENTURES ACQUISITION CORP (PEX) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 5 transactions totaling $4.4M, demonstrating a bearish sentiment with -$2.9M in net insider flow. The most recent transaction on Apr 22, 2009 involved a sale of 189,500 shares valued at $1.5M.
PEX Insider Activity Summary
Who Is Buying PEX Stock?
No significant insider buying has been recorded for PEX in the recent period.
Who Is Selling PEX Stock?
No significant insider selling has been recorded for PEX in the recent period.
Is APEX BIOVENTURES ACQUISITION CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PEX is bearish with an Insider Alignment Score of 17/100 and a net flow of -$2.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PEX Frequently Asked Questions
Understanding PEX Insider Activity
Insider trading at APEX BIOVENTURES ACQUISITION CORP (PEX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading PEX stock, having executed 5 transactions in the past 90 days. The most active insider is Bank Ag\ Deutsche (Executive), who has made 5 transactions totaling $4.4M.
Related Tools
Track APEX BIOVENTURES ACQUISITION CORP Insider Activity
Get notified when executives and directors at PEX file new Form 4 transactions